181 related articles for article (PubMed ID: 31442685)
21. Design, synthesis and biological evaluation of novel 3-alkylsulfanyl-4-amino-1,2,4-triazole derivatives.
Zhao PL; Chen P; Li Q; Hu MJ; Diao PC; Pan ES; You WW
Bioorg Med Chem Lett; 2016 Aug; 26(15):3679-83. PubMed ID: 27287368
[TBL] [Abstract][Full Text] [Related]
22. Rational design, synthesis and anti-proliferative evaluation of novel 1,4-benzoxazine-[1,2,3]triazole hybrids.
Bollu R; Palem JD; Bantu R; Guguloth V; Nagarapu L; Polepalli S; Jain N
Eur J Med Chem; 2015 Jan; 89():138-46. PubMed ID: 25462234
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis, in vitro Antiproliferative Activity, Binding Modeling of 1,2,4,-Triazoles as New Anti-Breast Cancer Agents.
Genc M; Karagoz Genc Z; Tekin S; Sandal S; Sirajuddin M; Hadda Taibi B; Sekerci M
Acta Chim Slov; 2016 Dec; 63(4):726-737. PubMed ID: 28004087
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of 3-amino-1,2,4-triazole derivatives as potential anticancer compounds.
Grytsai O; Valiashko O; Penco-Campillo M; Dufies M; Hagege A; Demange L; Martial S; Pagès G; Ronco C; Benhida R
Bioorg Chem; 2020 Nov; 104():104271. PubMed ID: 32992279
[TBL] [Abstract][Full Text] [Related]
25. Discovery of novel hybrids of diaryl-1,2,4-triazoles and caffeic acid as dual inhibitors of cyclooxygenase-2 and 5-lipoxygenase for cancer therapy.
Cai H; Huang X; Xu S; Shen H; Zhang P; Huang Y; Jiang J; Sun Y; Jiang B; Wu X; Yao H; Xu J
Eur J Med Chem; 2016 Jan; 108():89-103. PubMed ID: 26638042
[TBL] [Abstract][Full Text] [Related]
26. High affinity and low PARP-trapping benzimidazole derivatives as a potential warhead for PARP1 degraders.
Peng X; Li Y; Qu J; Jiang L; Wu K; Liu D; Chen Y; Peng J; Guo Y; Cao X
Eur J Med Chem; 2024 May; 271():116405. PubMed ID: 38678823
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and Biological Evaluation of Novel Triazoles Linked 7-hydroxycoumarin as Potent Cytotoxic Agents.
Farooq S; Hussain A; Qurishi MA; Hamid A; Koul S
Anticancer Agents Med Chem; 2018; 18(11):1531-1539. PubMed ID: 29298653
[TBL] [Abstract][Full Text] [Related]
28. Structure-based development of novel triazoles and related thiazolotriazoles as anticancer agents and Cdc25A/B phosphatase inhibitors. Synthesis, in vitro biological evaluation, molecular docking and in silico ADME-T studies.
Rostom SAF; Badr MH; Abd El Razik HA; Ashour HMA
Eur J Med Chem; 2017 Oct; 139():263-279. PubMed ID: 28803043
[TBL] [Abstract][Full Text] [Related]
29. Discovery of quinazoline-2,4(1H,3H)-dione derivatives as novel PARP-1/2 inhibitors: design, synthesis and their antitumor activity.
Zhou J; Ji M; Yao H; Cao R; Zhao H; Wang X; Chen X; Xu B
Org Biomol Chem; 2018 May; 16(17):3189-3202. PubMed ID: 29648554
[TBL] [Abstract][Full Text] [Related]
30. Secosteroid thiosemicarbazides and secosteroid-1,2,4-triazoles as antiproliferative agents targeting breast cancer cells: Synthesis and biological evaluation.
Ilovaisky AI; Scherbakov AM; Chernoburova EI; Povarov AA; Shchetinina MA; Merkulova VM; Salnikova DI; Sorokin DV; Bozhenko EI; Zavarzin IV; Terent'ev AO
J Steroid Biochem Mol Biol; 2023 Nov; 234():106386. PubMed ID: 37666392
[TBL] [Abstract][Full Text] [Related]
31. Discovery of Quinazoline-2,4(1
Zhou J; Ji M; Wang X; Zhao H; Cao R; Jin J; Li Y; Chen X; Sheng L; Chen X; Xu B
J Med Chem; 2021 Nov; 64(22):16711-16730. PubMed ID: 34748333
[TBL] [Abstract][Full Text] [Related]
32. Ganetespib overcomes resistance to PARP inhibitors in breast cancer by targeting core proteins in the DNA repair machinery.
Jiang J; Lu Y; Li Z; Li L; Niu D; Xu W; Liu J; Fu L; Zhou Z; Gu Y; Xia F
Invest New Drugs; 2017 Jun; 35(3):251-259. PubMed ID: 28111726
[TBL] [Abstract][Full Text] [Related]
33. Design and synthesis of novel 1,2,3-triazole derivatives of coronopilin as anti-cancer compounds.
Khazir J; Hyder I; Gayatri JL; Prasad Yandrati L; Nalla N; Chasoo G; Mahajan A; Saxena AK; Alam MS; Qazi GN; Sampath Kumar HM
Eur J Med Chem; 2014 Jul; 82():255-62. PubMed ID: 24910974
[TBL] [Abstract][Full Text] [Related]
34. Design and synthesis of novel 1,2,3-triazole-pyrimidine hybrids as potential anticancer agents.
Ma LY; Pang LP; Wang B; Zhang M; Hu B; Xue DQ; Shao KP; Zhang BL; Liu Y; Zhang E; Liu HM
Eur J Med Chem; 2014 Oct; 86():368-80. PubMed ID: 25180925
[TBL] [Abstract][Full Text] [Related]
35. Spirohydantoins and 1,2,4-triazole-3-carboxamide derivatives as inhibitors of histone deacetylase: Design, synthesis, and biological evaluation.
Aboeldahab AMA; Beshr EAM; Shoman ME; Rabea SM; Aly OM
Eur J Med Chem; 2018 Feb; 146():79-92. PubMed ID: 29396364
[TBL] [Abstract][Full Text] [Related]
36. Design and synthesis of novel 1,2,3-triazole-dithiocarbamate hybrids as potential anticancer agents.
Duan YC; Ma YC; Zhang E; Shi XJ; Wang MM; Ye XW; Liu HM
Eur J Med Chem; 2013 Apr; 62():11-9. PubMed ID: 23353743
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and anticancer evaluation of complex unsaturated isosteviol-derived triazole conjugates.
Khaybullin RN; Liang X; Cisneros K; Qi X
Future Med Chem; 2015; 7(18):2419-28. PubMed ID: 26653151
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and biological evaluation of novel triazoles and isoxazoles linked 2-phenyl benzothiazole as potential anticancer agents.
Kumbhare RM; Kosurkar UB; Janaki Ramaiah M; Dadmal TL; Pushpavalli SN; Pal-Bhadra M
Bioorg Med Chem Lett; 2012 Sep; 22(17):5424-7. PubMed ID: 22858144
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis, and biological evaluation of novel alkylsulfanyl-1,2,4-triazoles as cis-restricted combretastatin A-4 analogues.
Li YH; Zhang B; Yang HK; Li Q; Diao PC; You WW; Zhao PL
Eur J Med Chem; 2017 Jan; 125():1098-1106. PubMed ID: 27810596
[TBL] [Abstract][Full Text] [Related]
40. Synthesis, biological evaluation, and molecular modeling studies of new benzoxazole derivatives as PARP-2 inhibitors targeting breast cancer.
El-Ghobashy NM; El-Sayed SM; Shehata IA; El-Ashmawy MB
Sci Rep; 2022 Sep; 12(1):16246. PubMed ID: 36171229
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]